These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2976942)

  • 1. Influence of urapidil on in vitro platelet response to adrenaline and other aggregating agents.
    Emanuelli G; Anfossi G; Lanzio M; Mularoni E; Calcamuggi G; Brunello F; Busca GP; Ciani D
    Pharmacol Res Commun; 1988 Oct; 20(10):883-99. PubMed ID: 2976942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway.
    Sturk A; Asyee GM; Schaap MC; van Maanen M; ten Cate JW
    Thromb Res; 1985 Nov; 40(3):359-72. PubMed ID: 2934863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Potentiating effect of some fatty acids on platelet aggregation induced with ADP, collagen and 1-epinephrine].
    Musso R; Russo M; Raimondo V
    Boll Soc Ital Biol Sper; 1980 Mar; 56(6):569-75. PubMed ID: 7378191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of mithramycin on some platelet functions in vitro.
    Kubisz P; Klener P; Cronberg S
    Acta Haematol; 1980; 63(2):101-6. PubMed ID: 6445152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potentiation of adrenaline-induced in vitro platelet aggregation by ADP, collagen and serotonin and its inhibition by naftopidil and doxazosin in normal human subjects.
    Alarayyed NA; Graham BR; Prichard BN; Smith CC
    Br J Clin Pharmacol; 1995 Apr; 39(4):369-74. PubMed ID: 7640142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nifedipine on platelet function.
    Takahara K; Kuroiwa A; Matsushima T; Nakashima Y; Takasugi M
    Am Heart J; 1985 Jan; 109(1):4-8. PubMed ID: 3155583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urapidil inhibits 5-hydroxytryptamine induced platelet aggregation and 14C-5-hydroxytryptamine uptake in platelets.
    Storck J; Kirsten R
    Curr Med Res Opin; 1990; 12(2):86-92. PubMed ID: 2390867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The platelet-stimulating effect of adrenaline through alpha 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro.
    Steen VM; Holmsen H; Aarbakke G
    Thromb Haemost; 1993 Sep; 70(3):506-13. PubMed ID: 8259557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observations on human platelet aggregation in native whole blood: synergism and sensitivity to aggregating agents in vitro.
    Boyd DG; Davis RB
    Thromb Res; 1988 May; 50(3):429-36. PubMed ID: 3394122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of dermatan sulfate on in vitro human plasma coagulation, platelet aggregation and beta TG/PF4 release.
    Cofrancesco E; Colombi M; Gianese F; Cortellaro M
    Thromb Res; 1990 Feb; 57(3):405-14. PubMed ID: 2138364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of diclofenac sodium (feloran) on platelet aggregation.
    Tyutyulkova N; Gorantcheva Y; Lisitchkov T
    Methods Find Exp Clin Pharmacol; 1984 Jan; 6(1):21-5. PubMed ID: 6717167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction.
    Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G
    Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet aggregability in patients with a VVI pacemaker.
    Fazio S; Cittadini A; Sabatini D; Santomauro M; Cocozza M; Oliviero U; Chiariello M; Sacca L
    Pacing Clin Electrophysiol; 1993 Feb; 16(2):254-6. PubMed ID: 7680451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor.
    Ostermann G; Till U; Thielmann K
    Thromb Res; 1983 Apr; 30(2):127-36. PubMed ID: 6408754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation by adrenaline of agonist-induced responses in normal human platelets in vitro.
    Haaland HD; Holmsen H
    Platelets; 2011; 22(5):328-37. PubMed ID: 21388249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.
    Lanza F; Cazenave JP; Beretz A; Sutter-Bay A; Kretz JG; Kieny R
    Agents Actions; 1986 Aug; 18(5-6):586-95. PubMed ID: 3020942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-tocopherol: its inhibition on human platelet aggregation.
    Fong JS
    Experientia; 1976 May; 32(5):639-41. PubMed ID: 1278322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the effect of dopamine on the human platelet response.
    Anfossi G; Massucco P; Mularoni E; Cavalot F; Burzacca S; Mattiello L; Trovati M
    Clin Exp Pharmacol Physiol; 1992 Sep; 19(9):613-8. PubMed ID: 1382907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.